Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Inovio Biomedical Corporation.
Report 1: Inovio Biomedical Corporation (AMEX:INO), focused on the development of genetic vaccines for infections and cancers and a novel replacement for surgery to treat cancers, announced it has entered into definitive agreements to sell directly to institutional and accredited investors based in Singapore and North America, approximately 4,595,094 shares of the common stock of Inovio Biomedical at $3.52 per share, that will result in cash proceeds to Inovio...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.